Pharma major Lupin has started to rationalise its R&D operations. The company has decided to scale down the drug discovery programme to focus on more near-term and mid-term opportunities. CNBC-TV18's Ekta Batra gave us more details.
first published: Sep 12, 2017 08:33 pm
A collection of the most-viewed Moneycontrol videos.

The Bihar conundrum- freebies Vs Growth with NK Singh, Economist and Former MP

Will Nifty Cross 26,100 Hurdle On Weekly F&O Expiry? PhysicsWallah Lists Today|Opening Bell Live

How SIP Top-Ups Can Boost Your Wealth | Smart Investing Made Simple

Nifty Reclaims 26,000; Nifty Bank Hits New Life High| Groww Joins RS 1 Lk Cr Club| Closing Bell Live
You are already a Moneycontrol Pro user.

